Screening for Dementia: Family Caregiver Questionnaires Reliably Predict Dementia

References

1. ↵
   Brookmeyer R, Gray S, Kawas D. Projections of Alzheimer’s disease in the United States and the public health impact of delaying disease onset. Am J Public Health 1998; 88: 1337–42.

   OpenUrlCrossRefPubMedWeb of Science
2. ↵
   Ernst RL, Hay JW. The US economic and social costs of Alzheimer’s disease revisited. Am J Public Health 1994; 84: 1261–4.

   OpenUrlCrossRefPubMedWeb of Science
3. Gutterman E, Markowitz J, Lewis B, Fillit H. Cost of Alzheimer’s disease and related dementia in managed-Medicare. J Am Geriatr Soc 1999; 47: 1067–71.

   OpenUrl
4. Hebert LE, Beckett LA, Scherr PA, Evans DA. Annual incidence of Alzheimer disease in the United States projected to the years 2000 through 2050. Alzheimer Dis Assoc Disord 2001; 15: 169–73.

   OpenUrlCrossRefPubMedWeb of Science
5. ↵
   Pressley JC, Trott C, Tang M, Durkin M, Stern Y. Dementia in community-dwelling elderly patients: a comparison of survey data, medicare claims, cognitive screening, reported symptoms, and activity limitations. J Clin Epidemiol 2003; 56: 896–905.

   OpenUrlCrossRefPubMedWeb of Science
6. ↵
   Boustani M, Peterson B, Hanson L, Harris R, Lohr KN; U.S. Preventive Services Task Force. Screening for dementia in primary care: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 2003; 138: 927–37 [summary for patients in: Ann Intern Med 2003;138:I60.].

   OpenUrlCrossRefPubMedWeb of Science
7. ↵
   Medical Study News, July 16, 2004
8. ↵
   Boise L, Neal NB, Kaye J. Dementia assessment in primary care: results from a study in three managed care systems. J Gerontol A Biol Sci Med Sci 2004; 59: M621–6.

   OpenUrlAbstract/FREE Full Text
9. ↵
   Fillit H, Gutterman E, Lewis B. Donepezil use in managed Medicare: effect on health care costs and utilization. Clin Ther 1999; 21: 2173–85.

   OpenUrlCrossRefPubMedWeb of Science
10. ↵
    Schacter A, Davis K. Guidelines for the appropriate use of cholinesterase inhibitors in patients with Alzheimer’s disease. CNS Drugs 1999; 11: 281–8.

    OpenUrl
11. ↵
    Brunton SA. Alzheimer’s disease: the importance of early diagnosis. Fam Pract Recertification 2001; 23: 33–47.

    OpenUrl
12. ↵
    Max W, Webber P, Fox P. Alzheimer’s disease: the unpaid burden of caring. J Aging Health 1995; 7: 179–99.

    OpenUrlAbstract/FREE Full Text
13. ↵
    Ready R, Ott BR, Grace J. Validity of informant reports about AD and MCI patient’s memory. Alzheimer Dis Assoc Disord 2004; 18: 11–6.

    OpenUrlCrossRefPubMedWeb of Science
14. Isella V, Villa ML, Frattola L, Appollonio I. Screening cognitive decline in dementia; preliminary data on the Italian version of the IQCODE. Neurol Sci 2002; Suppl 2: S79–80.

    OpenUrl
15. Smith-Gamble V, Baiyeweu O, Perkins AJ, et al. Informant reports of changes in personality predict dementia in a population-based study of elderly African Americans and Yoruba. Am J Geriatr Psychiatry 2002; 10: 724–32.

    OpenUrlCrossRefPubMedWeb of Science
16. ↵
    Morris JC. The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology 1993; 43: 2412–4.
17. ↵
    Morris JC, Ernesto C, Schafer K, et al. Clinical dementia rating training and reliability in multi-center studies: the Alzheimer’s disease cooperative study experience. Neurology 1997; 48: 1508–10.

    OpenUrlAbstract/FREE Full Text
18. ↵
    Alzheimer’s Disease Research Center [homepage on the Internet]. St. Louis: Washington University; c2002 [cited 2005 May 27]. Available from: http://www.adrc.wustl.edu/.
19. ↵
    Kertesz A, Davidson W, Fox H. Frontal behavioral inventory: diagnostic criteria for frontal lobe dementia. Can J Neurol Sci 1997; 24: 29–36.

    OpenUrlPubMedWeb of Science
20. ↵
    Kertesz A, Davidson W, McCabe P, Munoz D. Behavioral quantification is more sensitive than cognitive testing in frontotemporal dementia. Alzheimer Dis Assoc Disord 2003; 17: 223–9.

    OpenUrlCrossRefPubMedWeb of Science
21. Kertesz A, Nadkarni N, Davidson W, Thomas AW. The Frontal Behavioral Inventory in the differential diagnosis of frontotemporal dementia. J Int Neuropsychol Soc 2000; 6: 460–8.

    OpenUrlCrossRefPubMedWeb of Science
22. Kertesz A, Davidson W, Fox H. The quantification of behavior in frontal lobe dementia. In: Kertesz A, Munoz D, editors. Pick’s disease and pick complex. New York: Wiley and Sons, Inc.; 1998. p. 47–67.
23. ↵
    Lawton MP, Kleban MH, Moss M, Rovine M, Glicksman A. Measuring caregiver appraisal. J Gerontol 1989; 44: P61–71.

    OpenUrlAbstract
24. ↵
    Sheikh JI, Yesavage JA. Geriatric depression scale (GDS): recent evidence and development of a shorter version. In: Brink TL, ed. Clinical gerontology: a guide to assessment and intervention. Binghamton (NY): Haworth Press; 1986. p. 165–273.
25. ↵
    Folstein MF, Folstein SE, McHugh PR. Mini-mental state: a practical method for grading the cognitive state of patients for the clinician. J Psychiat Res 1975; 12: 189–98.

    OpenUrlCrossRefPubMedWeb of Science
26. ↵
    Ford GR, Haley WE, Thrower SL, West CA, Harrell LE. Utility of Mini-Mental State Exam scores in predicting functional impairment among white and African American demented patients. J Gerontol A Biol Sci Med Sci 1996; 51: M185–8.

    OpenUrl
27. ↵
    Zanetti O, Geroldi C, Frisoni GB, Bianchetti A, Trabucchi M. Contrasting results between caregiver’s report and direct assessment of activities of daily living in patients affected by mild and very mild dementia: the contribution of the caregiver’s personal characteristics. J Am Geriatr Soc 1999; 47: 196–202.

    OpenUrlPubMedWeb of Science
28. Broday H, Pond D, Kemp NM, et al. The GPCOG: a new screening test for dementia designed for general practice. J Am Geriatr Soc 2002; 50: 531–4.

    OpenUrl
29. Knafelc R, Lo Giudice D, Harrigan S, et al. The combination of cognitive testing and an informant questionnaire in screening for dementia. Age Ageing 2003; 32: 541–7.

    OpenUrlAbstract/FREE Full Text
30. ↵
    Monnot M, Ross E. Psychosocial questionnaires accurately predict dementia. Poster presented at the 9th International Conference on Alzheimer’s Disease and Related Disorders; 2004 Jul 17–22; Philadelphia, Pennsylvania. Chicago: Alzheimer’s Association; 2004.
31. ↵
    Rosenthal R, Rosnow RL. Essentials of behavioral research: methods and data analysis. 2nd ed. Boston: McGraw-Hill; 1991. p. 316–23, 350–2.
32. ↵
    National Institute on Aging. Progress report on Alzheimer’s disease. Bethesda (MD): National Institute on Aging; 1998.
33. ↵
    Evans D. Estimated prevalence of Alzheimer’s disease in the United States. Milbank Q 1990; 68: 267–89.

    OpenUrlCrossRefPubMedWeb of Science
34. ↵
    2000 Census Results. Washington DC: United States Census Bureau; 2000. Available from http://www.census.gov/main/www/cen2000.html
35. ↵
    Gregory CA, Orrell M, Sahakian B, et al. Can frontotemporal dementia and Alzheimer’s disease be differentiated using a brief battery of tests?. Int J Geriatr Psychiatry 1997; 12: 375–83.

    OpenUrlCrossRefPubMedWeb of Science
36. ↵
    Cummings J. The Neuropsychiatric Inventory: assessing psychopathology in demented patients. Neurology 1997; 48(5 Suppl 6): S10–6.

    OpenUrl
37. ↵
    Depression in primary care: detection and diagnosis. Volume 1. Rockville (MD): Agency for Health Care Policy and Research, US Department of Health and Human Services; 1993.
38. ↵
    Beck AT. Beck Depression Inventory (BDI). San Antonio: Harcourt Brace & Company; 1996.
39. ↵
    Spreen O, Strauss E. A compendium of neuropsychological tests: administration, norms, and commentary, 2nd ed. New York: Oxford University Press; 1998.